Eli Lilly trial was halted regarding the s/c arm o
Post# of 147941
The EUA approval is for m/m.
The basis or justification for this approval is that Eli Lilly is a huge, powerful pharma company that want action in the covid19 therapy market, and has nothing to do with performance, efficacy, completed trials, p values, statistical significance, Primary Endpoints, Secondary Endpoints.